Stories

Bureaucracy’s primary instinct is self-preservation. Across government, non-profit, and private sectors, bureaucratic institutions work to present themselves as essential, celebrate their own past achievements, and deflect blame for failures onto those lower in the hierarchy. A recent example is a 15-page publication by federal health officials titled Delivering Results: Advancing Canada’s Tobacco Strategy, which reads largely as self-promotion. The document highlights standard talking points such as respect for Indigenous peoples and the distribution of large amounts of public funding to other agencies. It also congratulates itself for declining smoking rates and portrays Ottawa’s health bureaucracy as heroically improving Canadians’ lives.

U.S. regulators are close to approving Zyn nicotine pouches as safer than cigarettes. Experts at a FDA hearing support the claim that Zyn reduces risks, with minimal youth use. In contrast, Europe is restricting similar products due to youth concerns. The Association of Swedish Snus Manufacturers praises U.S. openness to harm reduction. FDA granted pre-market approval to Zyn last year, recognizing it as less harmful. The public can comment until March 4, 2026, before the FDA's final decision. Previously, FDA approved Swedish Match USA's tobacco snus as a reduced-risk product in 2019.

UK sales of caffeine pouches, doubling in a year, are attributed to Brits seeking quick energy boosts over coffee. Marketed on social media and available in various flavors, the pouches pose risks with high caffeine levels targeted at teens. Health professionals warn of potential addiction, health issues, and cognitive problems, especially among the youth. Easily accessible online and in stores, the pouches are less harmful than nicotine alternatives but raise concerns due to the direct bloodstream impact. Moderation of caffeine intake is essential for health benefits, unlike the larger doses the pouches may deliver. Vigilance is urged over the increasing popularity and potential dangers of these trendy alternatives.

David Zaruk, known as the Risk Monger, investigates Michael Bloomberg's influence on tobacco control policy, where Bloomberg funds organizations that align with his views. Bloomberg's philanthropic approach involves setting up groups under various names to control messaging and influence policy. Zaruk critiques the EU's precautionary principle, which hinders safer nicotine products regulation. The principle shifts the burden of proof onto proving absolute safety, causing challenges in various scientific fields. Regulatory actions based on this principle have led to removing products from the market, negatively impacting farmers. The tension between different definitions of precaution complicates decision-making in policy and science.

A nationwide study in the Netherlands identified that smoking, vaping, and snus use cause around 26,000 emergency department visits annually, with nicotine contributing to symptoms in 7% of patients. Conducted by Dr. Nicole Kraaijvanger from Leiden University Medical Center, the survey included 2,061 patients from 67 emergency departments. Results showed that smoking and vaping were linked to 44% of nicotine-related emergency visits, mostly due to traditional cigarette use. Vaping, considered safer, still led to issues like lung irritation and respiratory conditions. The impact may be underestimated due to severe cases not surveyed, emphasizing the need for preventive measures in healthcare settings.

The South Korean government will reclassify all nicotine-based products as tobacco to regulate e-cigarettes and liquid vape sales starting April 24. The revised law includes health warnings, advertising restrictions, and penalties for violations. Vending machines must be in adult-only areas, and flavored products aimed at youth are banned. Concerns over underage access to e-cigarettes have prompted stricter regulations due to minors using liquid e-cigarettes more than traditional cigarettes. Unmanned e-cigarette shops have exploited loopholes in tobacco laws, lacking age-verification systems and youth restrictions.

France's health agencies warn about the risks of vaping, including heart, lung, and cancer dangers, especially among teenagers. Anses cautions that vaping is not risk-free and can have long-term health effects. While vaping is seen as an alternative to smoking, it is not without risks, with concerns over exposure to toxic substances like aldehydes. Nicotine-containing products may impact cardiovascular health, respiratory systems, and potentially cancer development. The agency advises that vaping, while potentially aiding smoking cessation, should be temporary. An increase in long-term vaping among users is noted, especially among former smokers. Teens are drawn to vaping for various reasons, posing unique challenges. Long-term cancer risks are still being studied, particularly among non-smokers.

Cancer has deeply impacted my family, with members suffering from various types. Smoking was common among them, a significant risk factor. World Cancer Day has personal significance, but conflicting messaging from organizations like the WHO on smoking and nicotine adds frustration. The WHO's updated European Code Against Cancer blurs distinctions, falsely equating smoking with vaping. The failure to acknowledge harm reduction poses risks, especially since nicotine is wrongly believed to cause cancer. The WHO should prioritize clear risk communication, acknowledging the benefits of harm reduction and the experiences of those who have switched to safer alternatives, rather than pushing misleading narratives.

In tobacco control, “conflict of interest” has quietly undergone a semantic narrowing so severe that it now means almost one thing and one thing only: proximity to industry. Not proximity to power, not proximity to government, not proximity to advocacy organisations, not proximity to one’s own past statements or professional brand, just industry. Funding from a tobacco or nicotine company is treated not merely as a potential source of bias, but as a moral contaminant that disqualifies arguments in advance. Meanwhile, other forms of interest, ideological, reputational, institutional, and career-based, are waved through as if they were morally neutral, or worse, invisible.

Medsafe approved Aotearoa's first medically endorsed quit-vaping product, recognizing vaping addiction as a health issue. The product targets high-frequency nicotine exposure associated with vaping and facilitates controlled nicotine reduction. The Foundation highlights accessibility concerns, urging wider availability and affordability, especially for youth. They emphasize the product as part of a holistic approach to public health, underscoring the need for education, regulation, and prevention.